脉动神经调节用于监测和网络调节,在时间加
Yash Shashank Vakilna1, Ganne Chaitanya1, Muhammad Ubaid Hafeez1
1Texas Comprehensive Epilepsy Program, Department of Neurology, The University of Texas Health Science Center at Houston, Houston, Texas, USA.
Annals of clinical and translational neurology
|May 26, 2023
概括
这项研究探讨了使用深度大脑刺激 (DBS) 在监测的pulvinar. 它显示了实时发作跟踪和减少手术不合格患者的发作的潜力.
科学领域:
- 神经科学是一个神经科学.
- 神经学 神经学
- 生物医学工程 生物医学工程
背景情况:
- 深度大脑刺激 (DBS) 是一种被认可的治疗药物耐药性 (DRE) 的疗法,常常向thalamus (ANT) 的前核.
- 新兴研究表明,另一个乳头核,也可能具有治疗管理的治疗潜力.
- 确定有效的神经调节目标和监测策略对于难以治疗的至关重要.
相关概念视频
Seizures: Classification
453
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
453
Epilepsy and Seizures: Overview
230
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
230
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
354
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
354


